Skip to main content
. 2014 Dec 10;14:351. doi: 10.1186/s12888-014-0351-3

Figure 1.

Figure 1

The unblinded study design. Study HBBM consisted of 3 periods: a screening phase, a 7-day placebo lead-in phase that was blinded to investigators and patients, and a 6-week randomized treatment phase. All patients were hospitalized from Visits 2–5. Patients could be discharged after that time based upon clinical presentation.